Tirzepatide alternatives.
10 compounds compared to Tirzepatide, ranked by published evidence tier and regulatory status, not by what's marketed hardest.
People searching for tirzepatide alternatives are usually solving for money, tolerance, or ceiling. Tirzepatide is approved as Mounjaro for type 2 diabetes and Zepbound for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity, so this is not an evidence gap. It is a cost and coverage problem, a side-effect problem, or a search for something with a third receptor. Worth knowing before you compare: compounded or research-grade tirzepatide sold outside the regulated supply chain is not FDA-approved and carries quality and safety risks, so the cheaper version of the same molecule is not the same product.
Tirzepatide (development code LY3298176) is a synthetic, 39-amino-acid modified peptide engineered as a "twincretin," a single molecule that activates two incretin hormone receptors at once.
- 01RetatrutideB tierIn human trialstriple agonist
Acts through the glp-1 receptor agonism pathway, like Tirzepatide. In human trials.
- 02SemaglutideS tierFDA-approvedOzempic · Wegovy
Acts through the glp-1 receptor agonism pathway, like Tirzepatide. FDA-approved.
- 03LiraglutideS tierFDA-approvedVictoza · Saxenda
Acts through the glp-1 receptor agonism pathway, like Tirzepatide. FDA-approved.
- 04SurvodutideB tierIn human trialsBI 456906
Acts through the glp-1 receptor agonism pathway, like Tirzepatide. In human trials.
- 05MazdutideB tierIn human trialsIBI362 · LY3305677
Acts through the glp-1 receptor agonism pathway, like Tirzepatide. In human trials.
- 06CagriSemaC tierIn human trialscagrilintide + semaglutide
Acts through the glp-1 receptor agonism pathway, like Tirzepatide. In human trials.
- 07
- 08AOD-9604D tierResearch / preclinical
Same category: metabolic & glp-1. Research / preclinical.
- 09HGH Fragment 176-191F tierResearch / preclinicalhGH frag 176-191 · GH lipolytic fragment
Same category: metabolic & glp-1. Research / preclinical.
- 10
An “alternative” here means a compound that shares Tirzepatide's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.
PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.